Trademark: 87863129
Status Date
Monday, January 10, 2022
Filing Date
Wednesday, April 4, 2018
Published for Opposition
Tuesday, October 9, 2018
Abandoned Date
Monday, January 10, 2022
5 Biological preparations for medical purposes for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor specific for a canceror other disease-associated antigen; biological substances for medical use, namely, placental- derived cytotoxic T cells with a chimeric antigen receptor specific for a cancer or other disease-associated antigen; medical preparations that comprise placental-derived cytotoxic T cells with a chimeric antigen receptor specific for a cancer or other disease-associated antigen, for treatment of cancerand for immunotherapy; cellular immunotherapy compositions, namely, placental-derived cytotoxic T cells with a chimericantigen receptor specific for a cancer or other disease-associated antigen; andwritten instructional materials distributed in connection with the aforesaid goods
Jan 10, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 10, 2022
Abandonment - No Use Statement Filed
Dec 8, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 16, 2021
Teas Post Publication Amendment Received
May 13, 2021
Notice Of Approval Of Extension Request E-Mailed
May 12, 2021
Extension 5 Granted
May 4, 2021
Extension 5 Filed
May 12, 2021
Case Assigned To Intent To Use Paralegal
May 4, 2021
Teas Extension Received
Nov 11, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 9, 2020
Extension 4 Granted
Nov 9, 2020
Extension 4 Filed
Nov 9, 2020
Teas Extension Received
Oct 8, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 8, 2020
Teas Change Of Correspondence Received
Oct 8, 2020
Teas Change Of Owner Address Received
Apr 3, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 1, 2020
Extension 3 Granted
Apr 1, 2020
Extension 3 Filed
Apr 1, 2020
Teas Extension Received
Oct 9, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 7, 2019
Extension 2 Granted
Oct 7, 2019
Extension 2 Filed
Oct 7, 2019
Teas Extension Received
Apr 16, 2019
Notice Of Approval Of Extension Request E-Mailed
Apr 12, 2019
Extension 1 Granted
Apr 12, 2019
Extension 1 Filed
Apr 12, 2019
Teas Extension Received
Dec 4, 2018
Noa E-Mailed - Sou Required From Applicant
Oct 9, 2018
Official Gazette Publication Confirmation E-Mailed
Oct 9, 2018
Published For Opposition
Sep 19, 2018
Notification Of Notice Of Publication E-Mailed
Aug 31, 2018
Approved For Pub - Principal Register
Aug 30, 2018
Teas/Email Correspondence Entered
Aug 30, 2018
Correspondence Received In Law Office
Aug 28, 2018
Assigned To Lie
Aug 9, 2018
Teas Response To Office Action Received
Jul 24, 2018
Notification Of Non-Final Action E-Mailed
Jul 24, 2018
Non-Final Action E-Mailed
Jul 24, 2018
Non-Final Action Written
Jul 23, 2018
Assigned To Examiner
Apr 12, 2018
New Application Office Supplied Data Entered In Tram
Apr 7, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
